Reaction

Cardiac Valve Replacement Complication reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 244 reports · 2 co-occurring drugs

As of the last recalculation, Cardiac Valve Replacement Complication appears in 244 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is DABIGATRAN ETEXILATE (PRR 38.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dabigatran Etexilate3138.938.9
Dabigatran Etexilate Mesylate2735.535.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.